Korean disclosure
Medy-Tox said it has decided on a quarterly dividend of KRW 1,200 per share for 2026.
Unofficial English translation by ChickenStock; the Korean original prevails. Korean page · Original filing on DART ↗
Highlights
Translated AI summaryMedy-Tox said its board resolution on October 14, 2026 set a quarterly cash dividend of KRW 1,200 per common share. The total dividend amount is KRW 7.7 billion. The record date is October 29, 2026, and the scheduled payment date is November 9, 2026. The company listed the market dividend yield as 1.8%, and explained that this is the dividend per share as a percentage of the arithmetic average of closing prices over the past 1 trading days before the dividend decision date.
The dividend type is a quarterly dividend, paid in cash. There is no in-kind dividend.
The total number of common shares used to calculate the total dividend amount is 6,458,253 shares, excluding 840,244 treasury shares.
The board approves the dividend. No date for the shareholders' meeting was stated.
The company stated that differential dividends do not apply.
An AI model translated the Korean summary of this filing into English; every number is carried over from the Korean original. Reference information, not investment advice.
Key figures
- Dividend per share (common stock)
- KRW 1,200
- Market dividend yield (common stock)
- 1.8%
- Total dividend amount
- KRW 7.7 billion (KRW 7.7 billion, approx. KRW 7.7 billion)
- Record date
- October 29, 2026
- Scheduled dividend payment date
- November 9, 2026
- Board resolution date (decision date)
- October 14, 2026
Filing facts
- Filing type
- Dividend
- Report name
- Decision on Cash or In-kind Dividend
- Filed
- Oct 14, 2026
- Receipt number
- 20261014900164